Overview

Corporate Profile

Aptose Biosciences is a clinical-stage biotechnology company committed to discovering and developing targeted therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets at the leading edge of cancer research, coupled with validated biomakers to identify the optimal patient population for the Company's products. Aptose's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy, as well as enhanced efficacy when combined with existing anti-cancer therapies and regimens without overlapping toxicities. Aptose Biosciences Inc. is listed on NASDAQ under the symbol APTO and on the TSX under the symbol APS.

Stay Connected

Receive Email Alerts
Sign up to receive email alerts whenever Aptose Biosciences, Inc. posts new information to the site. Just enter your email address and click Submit.
 

Contact Information

Investor Relations
647-479-9825
ir@aptose.com

Data provided by Nasdaq. Minimum 15 minutes delayed.